Early Development Asset Lead

The Early Development Asset Lead serves as a scientific and program leadership role within Ipsen's Early Development and Innovation organization, accountable for integrated development strategy and execution for early-stage therapeutic assets from drug candidate nomination through first-in-human clinical trials. The position leads a cross-functional team to ensure programs advance with scientific rigor and strategic clarity while maintaining alignment with therapeutic area strategies. The role involves presenting plans and recommendations to governance bodies and serving as the scientific champion for assigned programs.